| 1 | What enlightenment has the development of lung cancer bone metastasis brought in the last 22 years | 3.0 | 2 | Citations (PDF) |
| 2 | A Comprehensive Analysis of LYAR in Colorectal Cancer: Prognostic Marker and Therapeutic Target | 1.3 | 1 | Citations (PDF) |
| 3 | Global bibliometric mapping of the research trends in artificial intelligence-based digital pathology for lung cancer over the past two decades | 2.1 | 7 | Citations (PDF) |
| 4 | Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues | 1.3 | 7 | Citations (PDF) |
| 5 | Clinical Significance of Integrin Subunit Beta 4 in Head and Neck Squamous Cell Carcinoma | 1.3 | 13 | Citations (PDF) |
| 6 | Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma | 1.3 | 5 | Citations (PDF) |
| 7 | Laryngeal Squamous Cell Carcinoma: Clinical Significance and Potential Mechanism of Cell Division Cycle 45 | 1.3 | 7 | Citations (PDF) |
| 8 | Clinical significance and effect of lncRNA BBOX1‑AS1 on the proliferation and migration of lung squamous cell carcinoma | 1.9 | 8 | Citations (PDF) |
| 9 | Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma | 2.9 | 8 | Citations (PDF) |
| 10 | Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum | 2.7 | 0 | Citations (PDF) |
| 11 | Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder cancer | 3.0 | 6 | Citations (PDF) |
| 12 | SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer | 1.8 | 7 | Citations (PDF) |
| 13 | Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods | 2.0 | 0 | Citations (PDF) |
| 14 | Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers | 2.6 | 18 | Citations (PDF) |
| 15 | Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer | 2.7 | 23 | Citations (PDF) |
| 16 | Comprehensive expression analysis reveals upregulated LUZP2 in prostate cancer tissues | 2.6 | 1 | Citations (PDF) |
| 17 | Upregulation of CCNB2 and Its Perspective Mechanisms in Cerebral Ischemic Stroke and All Subtypes of Lung Cancer: A Comprehensive Study | 2.5 | 17 | Citations (PDF) |
| 18 | Clinical assessment and molecular mechanism of the upregulation of Toll-like receptor 2 (TLR2) in myocardial infarction | 2.2 | 8 | Citations (PDF) |
| 19 | Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods | 2.0 | 5 | Citations (PDF) |
| 20 | Estrogenic activities of compound GL-1, isolated from <i>Ganoderma lucidum</i> | 2.0 | 3 | Citations (PDF) |
| 21 | Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays | 1.3 | 14 | Citations (PDF) |
| 22 | Ultrasound Image–Based Radiomics | 1.9 | 26 | Citations (PDF) |
| 23 | Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues | 4.1 | 12 | Citations (PDF) |
| 24 | Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer | 4.1 | 27 | Citations (PDF) |
| 25 | Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma | 2.4 | 4 | Citations (PDF) |
| 26 | The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma | 2.4 | 13 | Citations (PDF) |
| 27 | The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma | 2.7 | 22 | Citations (PDF) |
| 28 | MiRNA‐145‐5p expression and prospective molecular mechanisms in the metastasis of prostate cancer | 1.9 | 12 | Citations (PDF) |
| 29 | Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma | 2.7 | 29 | Citations (PDF) |
| 30 | Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma | 2.7 | 16 | Citations (PDF) |
| 31 | LPCAT1 overexpression promotes the progression of hepatocellular carcinoma | 5.4 | 40 | Citations (PDF) |
| 32 | Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance | 2.2 | 9 | Citations (PDF) |
| 33 | Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastoma | 4.1 | 5 | Citations (PDF) |
| 34 | Upregulation of microRNA miR-141-3p and its prospective targets in endometrial carcinoma: a comprehensive study | 4.1 | 14 | Citations (PDF) |
| 35 | Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment | 2.4 | 9 | Citations (PDF) |
| 36 | Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma | 4.1 | 16 | Citations (PDF) |
| 37 | Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods | 4.0 | 22 | Citations (PDF) |
| 38 | Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with Ferroptosis | 1.9 | 4 | Citations (PDF) |
| 39 | A novel risk signature that combines 10 long noncoding RNAs to predict neuroblastoma prognosis | 4.2 | 15 | Citations (PDF) |
| 40 | MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip | 1.8 | 30 | Citations (PDF) |
| 41 | The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study | 3.0 | 33 | Citations (PDF) |
| 42 | The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma | 3.0 | 13 | Citations (PDF) |
| 43 | Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanism | 2.9 | 13 | Citations (PDF) |
| 44 | Clinical significance of CCNE2 protein and mRNA expression in thyroid cancer tissues | 2.6 | 14 | Citations (PDF) |
| 45 | Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment | 3.3 | 10 | Citations (PDF) |
| 46 | Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis | 2.5 | 13 | Citations (PDF) |
| 47 | Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis | 5.4 | 29 | Citations (PDF) |
| 48 | Immunohistochemical basigin expression level in thyroid cancer tissues | 2.2 | 4 | Citations (PDF) |
| 49 | Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses | 2.4 | 8 | Citations (PDF) |
| 50 | Predictive value of hypoxia, metabolism and immune factors for prognosis in hepatocellular carcinoma: a retrospective analysis and multicenter validation study | 2.7 | 6 | Citations (PDF) |
| 51 | The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma | 1.6 | 6 | Citations (PDF) |
| 52 | Downregulation of miRNA‐126‐3p is associated with progression of and poor prognosis for lung squamous cell carcinoma | 2.2 | 11 | Citations (PDF) |
| 53 | Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses | 4.5 | 20 | Citations (PDF) |
| 54 | Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value | 2.4 | 20 | Citations (PDF) |
| 55 | Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma | 1.6 | 8 | Citations (PDF) |
| 56 | Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells | 2.7 | 14 | Citations (PDF) |
| 57 | Clinicopathological value and underlying molecular mechanism of annexin A2 in 992 cases of thyroid carcinoma | 2.9 | 8 | Citations (PDF) |
| 58 | Prognostic value of small nucleolar RNAs (snoRNAs) for colon adenocarcinoma based on RNA sequencing data | 3.0 | 22 | Citations (PDF) |
| 59 | Integrated expression analysis revealed RUNX2 upregulation in lung squamous cell carcinoma tissues | 1.9 | 9 | Citations (PDF) |
| 60 | RNA-Sequencing, Connectivity Mapping, and Molecular Docking to Investigate Ligand-Protein Binding for Potential Drug Candidates for the Treatment of Wilms Tumor | 1.4 | 5 | Citations (PDF) |
| 61 | Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma | 1.4 | 22 | Citations (PDF) |
| 62 | Downregulation of CDC14B in 5218 breast cancer patients: A novel prognosticator for triple-negative breast cancer | 1.6 | 7 | Citations (PDF) |
| 63 | Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma | 2.7 | 6 | Citations (PDF) |
| 64 | Upregulated expression of SAC3D1 is associated with progression in gastric cancer | 4.0 | 9 | Citations (PDF) |
| 65 | The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma | 1.9 | 11 | Citations (PDF) |
| 66 | Investigation of the clinical significance and molecular mechanism of miR‑21‑5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation | 1.9 | 11 | Citations (PDF) |
| 67 | Oncogenic value of microRNA‑15b‑5p in hepatocellular carcinoma and a bioinformatics investigation | 1.9 | 17 | Citations (PDF) |
| 68 | Expression levels and co‑targets of miRNA‑126‑3p and miRNA‑126‑5p in lung adenocarcinoma tissues: Αn exploration with RT‑qPCR, microarray and bioinformatic analyses | 3.0 | 16 | Citations (PDF) |
| 69 | Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways | 2.9 | 3 | Citations (PDF) |
| 70 | Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map | 2.9 | 3 | Citations (PDF) |
| 71 | Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306�cases | 2.9 | 6 | Citations (PDF) |
| 72 | Clinical value of microRNA‑198‑5p downregulation in lung adenocarcinoma and its potential pathways | 1.9 | 13 | Citations (PDF) |
| 73 | Expression significance and potential mechanism of hypoxia‐inducible factor 1 alpha in patients with myelodysplastic syndromes | 2.7 | 12 | Citations (PDF) |
| 74 | Expression and clinical significance of neuropilin-1 in Epstein-Barr virus-associated lymphomas | 1.6 | 6 | Citations (PDF) |
| 75 | Profiling of prognostic alternative splicing in melanoma | 1.9 | 8 | Citations (PDF) |
| 76 | Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry | 3.0 | 26 | Citations (PDF) |
| 77 | Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis | 5.4 | 18 | Citations (PDF) |
| 78 | Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data | 4.0 | 21 | Citations (PDF) |
| 79 | Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism | 2.7 | 15 | Citations (PDF) |
| 80 | Role of alternative splicing signatures in the prognosis of glioblastoma | 2.7 | 23 | Citations (PDF) |
| 81 | Ki-67/MKI67 as a Predictive Biomarker for Clinical Outcome in Gastric Cancer Patients: an Updated Meta-analysis and Systematic Review involving 53 Studies and 7078 Patients | 2.7 | 45 | Citations (PDF) |
| 82 | Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells | 2.9 | 8 | Citations (PDF) |
| 83 | Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas | 6.6 | 26 | Citations (PDF) |
| 84 | Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data | 6.6 | 39 | Citations (PDF) |
| 85 | Identification of potential agents for thymoma by integrated analyses of differentially expressed tumour‑associated genes and molecular docking experiments | 2.1 | 2 | Citations (PDF) |
| 86 | High throughput circRNA sequencing analysis reveals novel insights into the mechanism of nitidine chloride against hepatocellular carcinoma | 8.7 | 70 | Citations (PDF) |
| 87 | CD117 expression is correlated with poor survival of patients and progression of lung carcinoma:a meta-analysis with a panel of 2645 patients | 0.6 | 4 | Citations (PDF) |
| 88 | <p>Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients</p> | 1.7 | 38 | Citations (PDF) |
| 89 | <p>MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1</p> | 2.0 | 24 | Citations (PDF) |
| 90 | Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer | 3.0 | 21 | Citations (PDF) |
| 91 | Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis | 3.0 | 11 | Citations (PDF) |
| 92 | Gene profiling of HepG2 cells following nitidine chloride treatment: An investigation with microarray and Connectivity Mapping | 3.0 | 10 | Citations (PDF) |
| 93 | The expression, significance and function of cancer susceptibility candidate�9 in lung squamous cell carcinoma: A bioinformatics and in�vitro investigation | 4.0 | 20 | Citations (PDF) |
| 94 | Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data | 4.5 | 50 | Citations (PDF) |
| 95 | Expression of vimentin in nasopharyngeal carcinoma and its possible molecular mechanism: A study based on immunohistochemistry and bioinformatics analysis | 3.0 | 9 | Citations (PDF) |
| 96 | Clinical and genetic characteristics of female dystrophinopathy carriers | 2.9 | 24 | Citations (PDF) |
| 97 | The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets | 3.0 | 27 | Citations (PDF) |
| 98 | In�silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme | 3.0 | 33 | Citations (PDF) |
| 99 | miR‑146a‑5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression | 3.0 | 18 | Citations (PDF) |
| 100 | Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing | 3.0 | 9 | Citations (PDF) |
| 101 | Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression | 3.0 | 15 | Citations (PDF) |
| 102 | The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism | 2.9 | 31 | Citations (PDF) |
| 103 | <p>The coexistence of a Wilms&rsquo; tumor and renal cell carcinoma in children: a case report and review of the literature</p> | 1.7 | 7 | Citations (PDF) |
| 104 | <p>MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays</p> | 1.7 | 20 | Citations (PDF) |
| 105 | Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases | 3.0 | 21 | Citations (PDF) |
| 106 | Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data | 3.0 | 15 | Citations (PDF) |
| 107 | EBV as a potential risk factor for hepatobiliary system cancer: A meta-analysis with 918 cases | 3.0 | 10 | Citations (PDF) |
| 108 | A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma | 3.7 | 52 | Citations (PDF) |
| 109 | Primitive neuroectodermal tumors of the abdominal wall and vulva in children: Report of two cases and review of the literature | 1.1 | 7 | Citations (PDF) |
| 110 | A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma | 2.5 | 18 | Citations (PDF) |
| 111 | Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data | 2.9 | 11 | Citations (PDF) |
| 112 | Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics | 2.9 | 28 | Citations (PDF) |
| 113 | Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation | 2.9 | 40 | Citations (PDF) |
| 114 | Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics | 2.9 | 10 | Citations (PDF) |
| 115 | High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis | 2.9 | 20 | Citations (PDF) |
| 116 | Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification | 4.5 | 39 | Citations (PDF) |
| 117 | Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis | 3.0 | 14 | Citations (PDF) |
| 118 | Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645�cases from 9 microarray datasets | 2.9 | 24 | Citations (PDF) |
| 119 | MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis | 4.0 | 7 | Citations (PDF) |
| 120 | Biological function of UCA1 in hepatocellular carcinoma and its clinical significance: Investigation with in vitro and meta-analysis | 3.0 | 22 | Citations (PDF) |
| 121 | Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer | 3.0 | 11 | Citations (PDF) |
| 122 | In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells | 3.0 | 10 | Citations (PDF) |
| 123 | A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells | 1.9 | 17 | Citations (PDF) |
| 124 | Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma | 1.9 | 37 | Citations (PDF) |
| 125 | Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis | 3.0 | 41 | Citations (PDF) |
| 126 | Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining | 3.0 | 13 | Citations (PDF) |
| 127 | Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database | 3.0 | 4 | Citations (PDF) |
| 128 | The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored <i>in silico</i> using <scp>RNA</scp>‐sequencing and microarray data | 2.2 | 11 | Citations (PDF) |
| 129 | Diagnostic value of strand‐specific mi<scp>RNA</scp>‐101‐3p and mi<scp>RNA</scp>‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action | 2.2 | 23 | Citations (PDF) |
| 130 | Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis | 2.1 | 2 | Citations (PDF) |
| 131 | MicroRNA‑124‑3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study | 1.9 | 22 | Citations (PDF) |
| 132 | Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification | 2.0 | 1 | Citations (PDF) |
| 133 | Genomic analysis of small nucleolar RNAs identifies distinct molecular and prognostic signature in hepatocellular carcinoma | 3.0 | 16 | Citations (PDF) |
| 134 | A meta‑analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR‑193a‑5p in lung cancer | 1.9 | 20 | Citations (PDF) |
| 135 | Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches | 4.5 | 30 | Citations (PDF) |
| 136 | Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics | 2.9 | 15 | Citations (PDF) |
| 137 | Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma | 3.0 | 7 | Citations (PDF) |
| 138 | Downregulation of miR‑224‑5p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in�silico analyses | 3.0 | 35 | Citations (PDF) |
| 139 | DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride | 4.0 | 57 | Citations (PDF) |
| 140 | Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database | 3.0 | 18 | Citations (PDF) |
| 141 | Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis | 4.0 | 18 | Citations (PDF) |
| 142 | Microarray‑based bioinformatics analysis of the prospective target gene network of key miRNAs influenced by long non‑coding RNA PVT1 in HCC | 3.0 | 11 | Citations (PDF) |
| 143 | Regulatory interactions between long noncoding RNA LINC00968 and miR‑9‑3p in non‑small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA | 1.9 | 10 | Citations (PDF) |
| 144 | Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing | 2.9 | 14 | Citations (PDF) |
| 145 | Comprehensive analysis of the clinical significance and prospective molecular mechanisms of differentially expressed autophagy-related genes in thyroid cancer | 4.0 | 15 | Citations (PDF) |
| 146 | Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis | 2.2 | 21 | Citations (PDF) |
| 147 | Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma | 3.1 | 27 | Citations (PDF) |
| 148 | Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation | 2.2 | 29 | Citations (PDF) |
| 149 | Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR | 2.2 | 21 | Citations (PDF) |
| 150 | Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction | 1.4 | 54 | Citations (PDF) |
| 151 | Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases | 1.4 | 5 | Citations (PDF) |
| 152 | A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma | 2.2 | 15 | Citations (PDF) |
| 153 | A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma | 6.6 | 260 | Citations (PDF) |
| 154 | Long non‑coding RNAs in small cell lung cancer: A potential opening to combat the disease (Review) | 3.0 | 10 | Citations (PDF) |
| 155 | Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas | 9.9 | 87 | Citations (PDF) |
| 156 | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients | 4.5 | 72 | Citations (PDF) |
| 157 | Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis | 4.0 | 23 | Citations (PDF) |
| 158 | The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription‑quantitative polymerase chain reaction | 1.9 | 24 | Citations (PDF) |
| 159 | Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in�vitro experiments and bioinformatic analysis | 3.0 | 22 | Citations (PDF) |
| 160 | Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China | 2.6 | 31 | Citations (PDF) |
| 161 | Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases | 1.4 | 8 | Citations (PDF) |
| 162 | A meta-analysis of the lymphatic microvessel density and survival in gastric cancer with 1809 cases | 1.7 | 6 | Citations (PDF) |
| 163 | Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases | 1.7 | 47 | Citations (PDF) |
| 164 | An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients | 1.7 | 21 | Citations (PDF) |
| 165 | Clinical significances of p27 in digestive tract cancers: a comprehensive analysis on immunohistochemistry staining, published literatures, microarray and RNA-seq data | 1.7 | 4 | Citations (PDF) |
| 166 | Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially‑expressed circRNAs, lncRNAs, miRNAs and mRNAs | 4.0 | 34 | Citations (PDF) |
| 167 | Expression and clinical significance of ubiquitin‑specific‑processing protease 34 in diffuse large B‑cell lymphoma | 2.9 | 10 | Citations (PDF) |
| 168 | Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma | 3.0 | 30 | Citations (PDF) |
| 169 | Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1 | 3.0 | 62 | Citations (PDF) |
| 170 | A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance | 2.4 | 15 | Citations (PDF) |
| 171 | Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases | 1.1 | 6 | Citations (PDF) |
| 172 | Transshipment hub selection from a shipper's and freight forwarder's perspective | 7.5 | 29 | Citations (PDF) |
| 173 | A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases | 3.0 | 59 | Citations (PDF) |
| 174 | miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1 | 3.0 | 45 | Citations (PDF) |
| 175 | Down‐regulation of miR‐146a‐5p and its potential targets in hepatocellular carcinoma validated by a <scp>TCGA</scp>‐ and <scp>GEO</scp>‐based study | 2.2 | 38 | Citations (PDF) |
| 176 | Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data | 1.1 | 21 | Citations (PDF) |
| 177 | Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p | 2.7 | 75 | Citations (PDF) |
| 178 | Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significance | 2.9 | 33 | Citations (PDF) |
| 179 | Morphological characteristics of fatal pediatric hand, foot and mouth disease: A clinicopathological study with related receptors of EV71 | 3.0 | 6 | Citations (PDF) |
| 180 | Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification | 3.5 | 48 | Citations (PDF) |
| 181 | Long non-coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT-PCR and meta-analysis of 393 cases | 4.0 | 39 | Citations (PDF) |
| 182 | Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study | 3.0 | 23 | Citations (PDF) |
| 183 | Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound | 2.1 | 8 | Citations (PDF) |
| 184 | Cervical Cancer Growth Is Regulated by a c-ABL–PLK1 Signaling Axis | 0.6 | 44 | Citations (PDF) |
| 185 | Genetic analysis of the <i>dystrophin</i> gene in children with Duchenne and Becker muscular dystrophies | 2.2 | 9 | Citations (PDF) |
| 186 | Effect of miR-146a-5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation | 2.9 | 15 | Citations (PDF) |
| 187 | miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer | 5.4 | 24 | Citations (PDF) |
| 188 | The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases | 1.7 | 46 | Citations (PDF) |
| 189 | Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis | 1.4 | 43 | Citations (PDF) |
| 190 | The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 2.4 | 28 | Citations (PDF) |
| 191 | The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model | 3.1 | 50 | Citations (PDF) |
| 192 | Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma | 1.7 | 98 | Citations (PDF) |
| 193 | RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients | 1.7 | 28 | Citations (PDF) |
| 194 | Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation | 4.5 | 38 | Citations (PDF) |
| 195 | A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma | 1.7 | 29 | Citations (PDF) |
| 196 | Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study | 1.7 | 33 | Citations (PDF) |
| 197 | Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report | 1.7 | 5 | Citations (PDF) |
| 198 | Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining | 1.7 | 77 | Citations (PDF) |
| 199 | Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma | 1.7 | 55 | Citations (PDF) |
| 200 | Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases | 1.7 | 34 | Citations (PDF) |
| 201 | The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation | 1.7 | 18 | Citations (PDF) |
| 202 | The clinical value of lncRNA NEAT1 in digestive system malignancies: A comprehensive investigation based on 57 microarray and RNA-seq datasets | 1.7 | 29 | Citations (PDF) |
| 203 | Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics | 1.4 | 26 | Citations (PDF) |
| 204 | Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, <i>in vitro</i> and <i>in vivo</i> verification | 1.7 | 27 | Citations (PDF) |
| 205 | Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature | 1.7 | 18 | Citations (PDF) |
| 206 | The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics | 1.7 | 11 | Citations (PDF) |
| 207 | Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and in vitro investigation | 1.7 | 15 | Citations (PDF) |
| 208 | Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization | 1.7 | 28 | Citations (PDF) |
| 209 | An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps | 2.4 | 26 | Citations (PDF) |
| 210 | Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases | 2.4 | 48 | Citations (PDF) |
| 211 | High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma | 1.3 | 25 | Citations (PDF) |
| 212 | Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells | 5.4 | 57 | Citations (PDF) |
| 213 | Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma | 2.1 | 28 | Citations (PDF) |
| 214 | Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China | 3.2 | 3 | Citations (PDF) |
| 215 | Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study | 5.4 | 29 | Citations (PDF) |
| 216 | Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues | 1.1 | 31 | Citations (PDF) |
| 217 | Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer | 2.4 | 14 | Citations (PDF) |
| 218 | Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p | 1.1 | 37 | Citations (PDF) |
| 219 | Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis | 1.4 | 13 | Citations (PDF) |
| 220 | Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues | 5.4 | 30 | Citations (PDF) |
| 221 | Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues | 5.4 | 34 | Citations (PDF) |
| 222 | An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker | 2.2 | 27 | Citations (PDF) |
| 223 | Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis | 2.4 | 172 | Citations (PDF) |
| 224 | Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study | 1.4 | 27 | Citations (PDF) |
| 225 | The Prognostic Role of Ki-67/MIB-1 in Cervical Cancer: A Systematic Review with Meta-Analysis | 1.4 | 39 | Citations (PDF) |
| 226 | MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance | 3.2 | 36 | Citations (PDF) |
| 227 | Upregulation and Clinicopathological Significance of Long Non-coding NEAT1 RNA in NSCLC Tissues | 1.4 | 86 | Citations (PDF) |
| 228 | Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma | 3.0 | 57 | Citations (PDF) |
| 229 | MicroRNA-141 Is a Biomarker for Progression of Squamous Cell Carcinoma and Adenocarcinoma of the Lung: Clinical Analysis of 125 Patients | 1.8 | 25 | Citations (PDF) |
| 230 | Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer | 1.4 | 52 | Citations (PDF) |
| 231 | Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients | 2.4 | 26 | Citations (PDF) |
| 232 | Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism | 2.3 | 46 | Citations (PDF) |
| 233 | Expression of Tumor Necrosis Factor Receptor-associated Factor 6 in Lung Cancer Tissues | 1.4 | 22 | Citations (PDF) |
| 234 | Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis | 1.4 | 133 | Citations (PDF) |
| 235 | Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma | 3.0 | 16 | Citations (PDF) |
| 236 | Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues | 3.2 | 48 | Citations (PDF) |
| 237 | Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells | 2.5 | 32 | Citations (PDF) |
| 238 | Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues | 0.8 | 64 | Citations (PDF) |
| 239 | Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro | 2.4 | 38 | Citations (PDF) |
| 240 | Effects of miR-152 on Cell Growth Inhibition, Motility Suppression and Apoptosis Induction in Hepatocellular Carcinoma Cells | 1.4 | 54 | Citations (PDF) |
| 241 | Overexpression and Clinicopathological Contribution of DcR3 in Bladder Urothelial Carcinoma Tissues | 1.4 | 9 | Citations (PDF) |
| 242 | Expression and Prognostic Significance of lncRNA MALAT1 in Pancreatic Cancer Tissues | 1.4 | 140 | Citations (PDF) |
| 243 | Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents | 2.1 | 38 | Citations (PDF) |
| 244 | Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro | 3.1 | 112 | Citations (PDF) |
| 245 | Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib | 2.4 | 45 | Citations (PDF) |
| 246 | miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells | 2.4 | 250 | Citations (PDF) |
| 247 | Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET | 2.4 | 116 | Citations (PDF) |
| 248 | Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab | 7.5 | 113 | Citations (PDF) |
| 249 | Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma | 4.5 | 57 | Citations (PDF) |
| 250 | TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell | 3.0 | 21 | Citations (PDF) |
| 251 | Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase–quantitative polymerase chain reaction | 2.4 | 23 | Citations (PDF) |
| 252 | Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients | 0.8 | 20 | Citations (PDF) |
| 253 | Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells | 4.0 | 39 | Citations (PDF) |
| 254 | Over-expression of Decoy Receptor 3 in Gastric Precancerous Lesions and Carcinoma | 0.8 | 19 | Citations (PDF) |
| 255 | Expression of Heparanase in Hepatocellular Carcinoma Has Prognostic Significance: A Tissue Microarray Study | 3.3 | 24 | Citations (PDF) |
| 256 | Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic Prostate Cancer Based on Immunohistochemistry, Data Mining, and In Silico Analysis | 1.3 | 0 | Citations (PDF) |
| 257 | Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes | 1.4 | 14 | Citations (PDF) |
| 258 | Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methods | 0.0 | 18 | Citations (PDF) |
| 259 | From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma | 0.0 | 35 | Citations (PDF) |
| 260 | Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1 | 0.0 | 17 | Citations (PDF) |
| 261 | Small Nucleolar RNAs (snoRNAs)-Based Risk Score Classifier Predicts Overall Survival in Bladder Carcinoma | 1.4 | 3 | Citations (PDF) |
| 262 | Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways | 0.0 | 8 | Citations (PDF) |
| 263 | <i>Metadherin</i> Promotes the Development of Bladder Cancer by Enhancing Cell Division | 1.3 | 1 | Citations (PDF) |
